Halotestin 10mg

Dragon Pharma Halotestin — Fluoxymesterone 10mg Strength Catalyst

Dragon Pharma Halotestin delivers 10 mg of Fluoxymesterone per tablet. This is one of the most androgenically potent oral compounds available, engineered for athletes who require immediate neural drive and explosive power output.

Commonly referred to as "Halo," this agent does not function as a mass-building tool. Instead, it unlocks extreme strength surges, sharpened mental focus, and competitive aggression during the most critical phases of contest prep or powerlifting meet preparation.

Overview

Fluoxymesterone is a synthetic testosterone derivative structurally altered at the C9 and C11 positions. A fluorine atom and a hydroxyl group create a molecule with exceptionally high androgenic potency and comparatively modest anabolic activity.

The compound exhibits zero aromatization. It cannot convert to estradiol, which contributes to its characteristically dry, quality-enhancing effects without water retention or estrogenic bloating.

Originally synthesized in the 1950s, Halotestin has maintained its reputation as a premier strength-enhancing agent. Its severe hepatotoxic profile restricts use to brief, strategically timed windows.

Dragon Pharma manufactures each tablet with pharmaceutical precision. Recent independent laboratory analysis confirmed 9.88 mg per tablet, representing 98.8% of labeled potency and demonstrating exceptional batch consistency.

Benefits

• Explosive Strength Surges: Frequently produces 15–25% increases in raw power within 1–2 weeks. This makes it invaluable for shattering strength plateaus immediately before competition.
• Heightened Neural Drive: Significantly modulates central nervous system activity, generating intense mental focus, controlled aggression, and an unshakable competitive mindset.
• Dry Muscular Density: As a non-aromatizing agent, it promotes a hard, grainy appearance without subcutaneous fluid accumulation. Ideal for final-stage contest conditioning.
• Erythropoietic Stimulation: Increases red blood cell production and hematocrit, enhancing oxygen transport to skeletal muscle and supporting endurance capacity.
• Androgenic Well-Being: The high androgenic ratio can elevate confidence, libido, and overall assertiveness during the active phase.

Main Features

• Precisely dosed 10 mg oral tablets for controlled titration
• Synthetic testosterone derivative with C9 fluorination and C11 hydroxylation
• Zero aromatization potential; completely non-estrogenic
• Extremely high androgenic-to-anabolic ratio
• Rapid onset of CNS-mediated strength and aggression
• Independent laboratory verification of tablet potency

Ingredients

Each tablet contains 10 mg of Fluoxymesterone as the active pharmaceutical ingredient.

Inactive excipients include microcrystalline cellulose, magnesium stearate, and pharmaceutical-grade binders to ensure tablet integrity, hardness, and consistent dissolution.

All raw materials are sourced from certified suppliers and validated for chemical identity and purity prior to compression.

How to Use

Ingest tablets with water. Many athletes prefer administration with a small amount of dietary fat to support absorption of this lipophilic steroid hormone.

For pre-workout or pre-event application, take the dose 60–90 minutes before activity. This timing aligns peak plasma concentration with the demand window for maximum neural output.

When running a short cycle, divide the daily total into two or three administrations. This maintains stable blood levels and moderates hepatic exposure.

Store the container in a cool, dry place away from direct sunlight. Keep the desiccant intact to prevent moisture degradation.

Dosage

Pre-workout or pre-event dosing for men ranges from 10–20 mg. Take this 60–90 minutes before training or competition. This is the most common protocol among strength athletes.

Short-cycle application for men spans 20–30 mg daily, split into 2–3 doses. Limit this approach to 2–4 weeks maximum, typically in the final phase before a bodybuilding contest.

Advanced male users may briefly approach 30–40 mg daily. Do not exceed this threshold. Doses beyond 40 mg yield diminishing returns while exponentially amplifying adverse effects.

Halotestin is absolutely contraindicated for women. The extreme androgenic rating causes rapid, irreversible virilization even at micro-doses.

Side Effects

Hepatotoxicity is severe and immediate. The C17-alpha alkylation protects the molecule during first-pass metabolism but imposes extraordinary stress on hepatic enzymes.

Cycle length must remain minimal. Aggressive hepatoprotective supplementation with TUDCA and N-acetylcysteine is mandatory. Alcohol and all other hepatotoxic substances are strictly prohibited.

Cardiovascular strain is pronounced. Halotestin can produce dramatic blood pressure elevation and severely distort lipid profiles. Regular monitoring and cardiovascular support are essential.

Androgenic sequelae are common and often severe. These include acne vulgaris, accelerated male pattern baldness in genetically susceptible individuals, and increased body hair growth.

The compound causes profound hypothalamic-pituitary-gonadal axis suppression. Natural testosterone production shuts down rapidly. A comprehensive Post-Cycle Therapy protocol is non-negotiable.

Psychological effects include intense aggression and irritability. This agent is contraindicated for individuals with any history of mood disorders, anger management issues, or psychiatric conditions.

Some users report severe headaches and lethargy. These symptoms may necessitate immediate discontinuation of the compound.

Safety Information

This product is intended exclusively for research purposes and use by qualified male adults under appropriate supervision. It is not suitable for minors, women, or individuals with hepatic, cardiovascular, or psychiatric conditions.

Comprehensive liver support must begin before the first dose and continue through the entire protocol. Regular hepatic function panels are required.

A structured PCT using Clomiphene or Tamoxifen must commence within 8–12 hours of the final tablet. This restores endogenous testosterone and prevents prolonged hypogonadal symptoms.

Discontinue immediately and seek emergency medical evaluation if jaundice, severe abdominal pain, dark urine, or neurological symptoms develop.

Never exceed 4 weeks of continuous use. The risk-to-benefit ratio deteriorates rapidly beyond this window.